Biosynex SA (EPA:ALBIO)
France · Delayed Price · Currency is EUR 0.8920
+0.0100 (1.13%)
Sep 4, 2026, 4:17 PM CET
Biosynex Market Cap
Biosynex has a market cap or net worth of €16.44 million as of September 4, 2026. Its market cap has decreased by -25.05% in one year.
Market Cap
16.44M
Enterprise Value
69.63M
Revenue
95.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.89
ChartMarket Cap Chart
Since March 25, 2011, Biosynex's market cap has increased from 8.12M to 16.44M, an increase of 102.42%. That is a compound annual growth rate of 4.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 16.44M | 47.14% |
| Dec 31, 2025 | 11.17M | -39.63% |
| Dec 31, 2024 | 18.51M | -78.44% |
| Dec 29, 2023 | 85.85M | -39.13% |
| Dec 30, 2022 | 141.04M | -51.35% |
| Dec 31, 2021 | 289.89M | 91.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 199.35M |
| Median Technologies | 161.05M |
| Guerbet | 95.50M |
| Theraclion | 53.52M |
| Novacyt | 36.69M |
| Mauna Kea Technologies | 30.16M |
| Diagnostic Medical Systems | 26.69M |
| Implanet | 25.60M |